Article Details
Retrieved on: 2021-03-10 17:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
After this action, Third Rock Ventures II, L.P. now owns 7,750,349 shares of Jounce Therapeutics Inc., valued at $17,037,500 using the latest closing ...
Article found on: newsheater.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here